tirzepatide from lilly Eli (LLY) Gets Nod to Launch Weight-Loss Drug Mounjaro in Hong Kong Mounjaro® (tirzepatide) injection and Zepbound®

NMDA receptors are opened by a combination of glutamate binding and a voltage trigger

Multiple randomized controlled trials show that GLP-1 agonists combined with insulin secretagogues (Glipizide, glimepiride) increase hypoglycemia incidence by 25-30% without additional A1C benefit compared to GLP-1 monotherapy

J Eur Acad Dermatol Venereol 2007;21:705 Adibi S, Suarez P, Bouquot JE

We review each one on the same four points: what it is best for, the trust signals it shows, the watch-outs, and a quick takeaway

What approach do the guidelines in the article favor instead

Weight loss is not recommended during pregnancy and you should discontinue Zepbound when a pregnancy is recognized